Dr. Kavanaugh's clinical research primarily explores rheumatoid arthritis and psoriatic arthritis, focusing on their pathophysiology and the effects of novel immunomodulatory therapies.

Discover how rheumatoid arthritis advances through distinct stages, the symptoms at each phase, and treatment approaches that ...

High antibody titers of anti–citrullinated peptide antibodies, rheumatoid factor, and certain baseline factors predict RA ...

Filgotinib, a Janus Kinase 1 inhibitor, remains well-tolerated for up to 8 years with consistent efficacy in patients with ...

Differences between rheumatoid arthritis (RA) and ankylosing spondylitis (AS) include the joints they affect and who are most likely to develop each condition. Some treatments may work for one but ...

Figure 1: Role of TL1A in propagating inflammatory responses in rheumatoid arthritis. Of note, circulating and synovial levels of DcR3 are also increased in patients with RA in comparison with ...

Groundbreaking research reveals how gut health could reshape rheumatoid arthritis treatment offering new hope for symptom ...

Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA). Different parts of the immune system have been targeted by monoclonal ...

The pathology of the disease process often leads to the destruction of articular cartilage and ankylosis of the joints. Rheumatoid arthritis can also produce diffuse inflammation in the lungs ...

PREGNENOLONE (Δ 5-pregnen-3βol-20-one) has recently been recommended as effective in the treatment of rheumatoid arthritis. 1–5 Since Cortisone (17 hydroxy-11 dehydrocorticosterone ...